APA

Prat A., Cheang M. C. U., Galván P., Nuciforo P., Paré L., Adamo B., Muñoz M., Viladot M., Press M. F., Gagnon R., Ellis C. & Johnston S. (20170221). Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. : JAMA oncology.

Chicago

Prat Aleix, Cheang Maggie C U, Galván Patricia, Nuciforo Paolo, Paré Laia, Adamo Barbara, Muñoz Montserrat, Viladot Margarida, Press Michael F, Gagnon Robert, Ellis Catherine and Johnston Stephen. 20170221. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. : JAMA oncology.

Harvard

Prat A., Cheang M. C. U., Galván P., Nuciforo P., Paré L., Adamo B., Muñoz M., Viladot M., Press M. F., Gagnon R., Ellis C. and Johnston S. (20170221). Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. : JAMA oncology.

MLA

Prat Aleix, Cheang Maggie C U, Galván Patricia, Nuciforo Paolo, Paré Laia, Adamo Barbara, Muñoz Montserrat, Viladot Margarida, Press Michael F, Gagnon Robert, Ellis Catherine and Johnston Stephen. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. : JAMA oncology. 20170221.